As Congo Outbreak Continues, Study Finds Low-Dose Mpox Vaccine Still Offers Protection
THURSDAY, Dec. 14, 2023 (HealthDay News) — Mpox is making headlines again, as an outbreak of severe disease in the Democratic Republic of Congo in Africa has infected thousands of people and killed hundreds. Amid this worrying scenario, researchers at New York University (NYU) offer a glimmer of good news:Continue Reading